BOSTON — Forever chemicals. They’re everywhere — from non-stick pans to seafood to cosmetics. Researchers say these chemicals, often called PFAS Per-for polyfluoroalkyl substances, can remain in our ...
A new study led by researchers at Moffitt Cancer Center found that blood-based DNA markers known as protein epiScores can help predict which colorectal cancer patients face a higher risk of cancer ...
Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...
This blood test may predict heart disease better than ‘bad' cholesterol. Why aren't more getting it?
“Bad,” or LDL, cholesterol is a major risk factor for heart disease and most people are screened for it as part of their yearly physicals. There’s another marker in the blood that may be a better ...
“Bad,” or LDL, cholesterol is a major risk factor for heart disease and most people are screened for it as part of their yearly physicals. There’s another marker in the blood that may be a better ...
When it comes to cancer, waiting for symptoms may soon be old news. Telehealth company Hims & Hers began offering a blood test this week that screens for a wide range of cancers before warning signs ...
A telehealth company that generated buzz last year with a defiant Super Bowl ad hawking weight-loss drugs is back for this year’s championship with a socially charged pitch around longevity. “Rich ...
Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech has now sent off data for a potential FDA approval. Galleri works as a simple blood test that ...
NEW YORK – Quanterix said Tuesday that it has submitted a 510(k) premarket notification to the US Food and Drug Administration for its Lucent AD Complete multi-analyte algorithmic blood test for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results